Professional Documents
Culture Documents
Quality Assurance
(PHTC 941)
Course Instructors:
Dr. Shahir Aziz
Validation
• Validation principles
• Validation Vs. Qualification
• Validation approaches
• Qualification Stages
• Calibration and Verification
• Change Control
• Based on level of protection, Areas are classified into 3 main levels as shown in table.
Further sublevels can be introduced according to more specific standards such as the
number of airborne particulates and their sizes in micron (µm).
Some of the typical HVAC system parameters that should be qualified for
a pharmaceutical facility may include:
5
Dr. Shahir Aziz – QA course (PHTC 941) – Winter 2020 5
Recall: Safety, Hygiene and Training Personnel
Personnel
Qualified/
Safety
Trained
Hygiene
6
Dr. Shahir Aziz – QA course (PHTC 941) – Winter 2020
Documentation Types and Guidelines
Documentation Specifications
Manufacturing formula
• Must be approved,
and Process instructions
signed and dated by
authorized person.
Manufacturing
formula and
Process instructions
Operational
Procedures
Records
Is defined as the list of tests, analytical procedures, storage conditions and acceptance
criteria that define the standard quality of a given material (Raw, intermediate or finished
goods).
Manufacturer
Information
Sampling or testing
directions
Qualitative and
quantitative
requirements
Storage Conditions
and shelf life
A document or set of documents specifying the raw materials with their quantities and
the packaging materials, together with a detailed description of the procedures and
precautions required to produce a specified quantity of a finished product as well as the
processing instructions, including the in-process controls.
5. Testing and analysis procedure (e.g.: how to analyze and compare samples to the
standard required specifications in QC)
Batch Packaging The record should carry the batch number and the quantity of
Record bulk product to be packed.
• Financial: validation often requires the time of specialized personnel and expensive
technology.
Valid Valid
Not Reliable Reliable
• There should be qualification and validation Protocols and Reports describing the
qualification and validation study to be performed, including;
Prospective and
Retrospective
Concurrent
validation
validation
Based on evidence
Based on the
obtained through
analysis of historical
testing (before and
data (not preferred)
during production)
Applied for:
• New premises, equipment, utilities, systems, processes and procedures.
• At periodic intervals and when major changes have been made.
In accordance to:
Validation Master Plan (VMP) that reflect all the key elements of the validation
program.
http://apps.who.int/medicinedocs/en/d/Js14057e/19.html#Js14057e
http://apps.who.int/medicinedocs/en/d/Js14057e/19.html#Js14057e
• The Change control process should be done under the coordination of a change control
management that gathers qualified and trained personnel for each specific change
type.
• The procedure should describe the actions to be taken, including the need for and
extent of requalification or revalidation to be done.
2. Cleaning validation
Note:
Calibration and verification of equipment, instruments and other devices, as applicable,
used in production and quality control, should be performed at regular intervals (e.g.:
every 3 months).
Case 1: Answer
• The QA officer refused to release this batch. Why do you think this happened?
• This equipment change should be handled with a change control document.
• Any change that occurs within a GMP process needs to be documented with a change
control record for future tracking.
• In this case, the required spare part was changed without any documentation recording
this event, which is not accepted according to the GMP rules & regulations.
• Sometimes if the spare part required, is a critical part that would impact the product
quality in a way or another, a risk assessment document might be required to assess the
risk/s that could occur with such a change. In this case a risk assessment document is
derived from the change control record. In the above case the QA officer shall raise a
quality incident because the normal procedures were not followed and all required
documents shall be initiated and then finalized, to be able to release the relevant batch.
• A QA officer was having the daily tour around the production area, to make sure that all
processes are compliant with all procedures and instructions.
• Along his tour he found a new processing operator in one of the manufacturing rooms
working on a batch. The QA went in to get to know him, and throughout the discussion it
was clear enough that this new operator had more than 10 years of experience, which is
logically enough to start working from the very first day.
• Instead of just passing by, the QA officer decided to raise a Quality investigation/
Incident. Why do you think this has happened?
Case 2: Answer
• A warehouse operator had a very good idea that could save a lot of time during the
receiving process; he went and asked his line manager and QA officer to update the
required document to reflect these changes. The warehouse operator applied the
changes immediately to his daily routine to save up the agreed upon time, and
simultaneously the document was being updated.
• Do you find anything wrong with what the warehouse operator did?
Case 3: Answer
Any new process, method or initiative needs to be validated & documented ahead of
application. This warehouse operator got excited about his idea and forgot that he cannot
apply this change without having the relevant instruction or working procedure updated &
approved by quality, to make sure it has no quality impact, and have his colleagues and the
required personnel trained on this new process.
4. World Health Organization. 2009. Handbook: good laboratory practice (GLP): quality
practices for regulated non-clinical research and development -. Geneva : WHO Library,
2009. ISBN 978 92 4 154755 0.
5. U.S. Department of Health and Human Services Food and Drug Administration. 2009.
Guidance for Industry Q10 Pharmaceutical Quality System. Silver Spring : Food and Drug
Administration (FDA), 2009.
THANK YOU